PharmaVoice Profile Banner
PharmaVoice Profile
PharmaVoice

@PharmaVoice

Followers
35K
Following
573
Media
4K
Statuses
8K

PharmaVoice is the leading community for life sciences leaders to share their stories, voices and ideas. Subscribe at https://t.co/VQzsyqTs0b

Washington, D.C.
Joined December 2008
Don't wanna be here? Send us removal request.
@PharmaVoice
PharmaVoice
5 months
Join us for an exclusive event on the latest in oncology research! Top experts will break down cutting-edge advancements, emerging treatment trends, and what’s next for the industry. Don’t miss this insightful and free event. https://t.co/n47QYnkK0y
Tweet media one
0
0
2
@PharmaVoice
PharmaVoice
2 years
PharmaVoice’s daily newsletter delivers must-read insight and analysis for pharma leaders. Sign up today:
Tweet card summary image
pharmavoice.com
Sign up for PharmaVoice: The free email newsletter covering the top news and trends for life science & healthcare industry leaders.
2
0
3
@PharmaVoice
PharmaVoice
2 years
PharmaVoice and @BioPharmaDive are partnering to host a two-day live event — The Next Frontier of the Life Sciences — that will examine the top trends shaping the drug industry. Check out the multi-session agenda and register here: https://t.co/D6Oohj954s
Tweet media one
0
0
2
@PharmaVoice
PharmaVoice
2 years
PharmaVoice and @BioPharmaDive are partnering to host a two-day live event — The Next Frontier of the Life Sciences — that will examine the top trends shaping the drug industry. Check out the multi-session agenda and register here: https://t.co/D6Oohj954s
Tweet media one
0
1
1
@PharmaVoice
PharmaVoice
2 years
Join the journalists at PharmaVoice, along with key industry leaders across biotech and pharma, for an immersive and thought-provoking event around rare diseases. Learn more when you register today: https://t.co/rocVpIvwWS
Tweet media one
0
0
1
@PharmaVoice
PharmaVoice
2 years
Join the journalists at PharmaVoice, along with key industry leaders across biotech and pharma, for an immersive and thought-provoking event around rare diseases. Learn more when you register today: https://t.co/rocVpIvwWS
Tweet media one
0
0
1
@PharmaVoice
PharmaVoice
2 years
Join the journalists at PharmaVoice, along with key industry leaders across biotech and pharma, for an immersive and thought-provoking event around rare diseases. Learn more when you register today: https://t.co/rocVpIvwWS
Tweet media one
0
0
0
@PharmaVoice
PharmaVoice
2 years
Join the journalists at PharmaVoice, along with key industry leaders across biotech and pharma, for an immersive and thought-provoking event around rare diseases. Learn more when you register today: https://t.co/aVbREiKzyj
Tweet media one
6
0
1
@PharmaVoice
PharmaVoice
2 years
After years of struggling to create a pharmaceutical birth control option for men, it might soon be time for the fellas to get their turn taking “the pill.” #ReproductiveHealth https://t.co/1ifRFzwidV
Tweet card summary image
pharmavoice.com
Drug developers have tried — and failed — to create a male contraceptive for decades. Now, one group of scientists might be on the verge of success.
0
0
1
@PharmaVoice
PharmaVoice
2 years
Conversations around #burnout typically put the onus on employees to deal with it — get more sleep, eat well, etc. But @CMaslach, a leading burnout expert, says companies should instead target the workplace systems that lead to it. #Biotech https://t.co/5W9ORno8sF
Tweet card summary image
pharmavoice.com
One of the country’s leading burnout experts explains how companies can help keep high stress from becoming a high desire to leave the job.
0
0
0
@PharmaVoice
PharmaVoice
2 years
As experts wrestle with COVID-19’s lab leak versus animal market debate, here’s what experts say are the suspected #origins for some of the worst #viral outbreaks in the last century. https://t.co/wALsyQBUXt
Tweet card summary image
pharmavoice.com
As experts wrestle with COVID-19’s lab leak versus animal market debate, here’s what experts say are the suspected origins for some of the worst viral outbreaks in the last century.
0
1
2
@PharmaVoice
PharmaVoice
2 years
There's less than one month to go until nominations close for the 2023 #PharmaVoice100 class. Have you nominated an inspiring life science #leader in your life yet? https://t.co/HBL6dRWe6j
Tweet card summary image
pharmavoice.com
Our new approach to recognizing inspiring leaders across the industry.
0
1
2
@PharmaVoice
PharmaVoice
3 years
Join us on tomorrow for our Future of Ophthalmology live virtual event. We'll sit down with various pharma industry experts to discuss new technology, new innovations, patient access and more. Take a peek at the topics and save your seat: https://t.co/zLzwx2YdQp
Tweet media one
0
0
1
@PharmaVoice
PharmaVoice
3 years
Join us on March 8th for our Future of Ophthalmology live virtual event. We'll sit down with various pharma industry experts to discuss new technology, new innovations, patient access and more. Take a peek at the topics and save your seat: https://t.co/zLzwx2YdQp
Tweet media one
0
0
1
@PharmaVoice
PharmaVoice
3 years
Know an inspirational leader in the life sciences? Nominate them to be a 2023 PharmaVoice 100 by April 1! https://t.co/HBL6dRWe6j
Tweet card summary image
pharmavoice.com
Our new approach to recognizing inspiring leaders across the industry.
0
0
0
@PharmaVoice
PharmaVoice
3 years
We want your feedback! Let us know how our journalism brings value to your day and where we can improve in our annual reader survey. https://t.co/dykCxTstRG
0
0
0
@PharmaVoice
PharmaVoice
3 years
.@VivekGRamaswamy Ramaswamy, the former CEO of @Roivant and face of the “anti-woke” business movement, is running for president. Here's a look at his pharma legacy and where he stands on the issues. https://t.co/wnMCSMuCUL
Tweet card summary image
pharmavoice.com
The former CEO of Roivant, who became the face of the “anti-woke” business movement, is now running for the 2024 Republican presidential nomination. Here’s what he stands for. 
0
0
1
@PharmaVoice
PharmaVoice
3 years
With FDA’s longtime neuro head Billy Dunn out, industry is reeling over how the agency’s new acting director, Teresa Buracchio, could handle upcoming approval decisions – including today's expected decision on @ReataPharma's Friedreich’s Ataxia treatment. https://t.co/YFpk3EpIqM
Tweet card summary image
pharmavoice.com
The FDA’s longtime neuroscience head Billy Dunn stepped down, leaving industry reeling over how the agency’s new acting director could handle upcoming approval decisions.
0
0
0
@PharmaVoice
PharmaVoice
3 years
Know an inspirational leader in the life sciences? Nominate them for the 2023 PharmaVoice 100 by April 1. https://t.co/HBL6dRWe6j
Tweet card summary image
pharmavoice.com
Our new approach to recognizing inspiring leaders across the industry.
0
0
0